Boning up on lanthanum

Seminars in Dialysis

Volumn 19, Issue 1, 2006, Pages 87-89

  Berns, Jeffrey S ^a   Korbin, Sidney ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

LANTHANUM; LANTHANUM CARBONATE;

BIOPSY; BONE; CHEMISTRY; HUMAN; METABOLISM; NOTE; PATHOLOGY; RENAL REPLACEMENT THERAPY;

BIOPSY; BONE AND BONES; HUMANS; LANTHANUM; RENAL DIALYSIS;

EID: 33645365508     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2006.00127a.x     Document Type: Note

References (22)

1. Behets GJ Verberckmoes SC D'Haese PC De Broe ME Lanthanum carbonate: a new phosphate binder. Curr Opin Nephrol Hypertens 13 403 409 2004
2. Drueke TB Intestinal absorption of aluminium in renal failure. Nephrol Dial Transplant 17 suppl 2 13 16 2002
3. Hutchison AJ Maes B Vanwalleghem J Asmus G Mohamed E Schmieder R Backs W Jamar R Vosskuhler A Efficacytolerabilityand safety of lanthanum carbonate in hyperphosphatemia: a 6-monthrandomizedcomparative trial versus calcium carbonate. Nephron Clin Pract 100 c8 c19 2005
4. Finn WF Joy MS Hladik G Efficacy and safety of lanthanum carbonate for reduction of serum phosphorus in patients with chronic renal failure receiving hemodialysis. Clin Nephrol 62 193 201 2004
5. Joy MS Finn WF Randomizeddouble-blindplacebo-controlleddose- titrationphase III study assessing the efficacy and tolerability of lanthanum carbonate: a new phosphate binder for the treatment of hyperphosphatemia. Am J Kidney Dis 42 96 107 2003
6. Al-Baaj F Speake M Hutchison AJ Control of serum phosphate by oral lanthanum carbonate in patients undergoing haemodialysis and continuous ambulatory peritoneal dialysis in a short-termplacebo-controlled study. Nephrol Dial Transplant 20 775 782 2005
7. Hutchison AJ Speake M Al-Baaj F Reducing high phosphate levels in patients with chronic renal failure undergoing dialysis: a 4-weekdose- findingopen-label study with lanthanum carbonate. Nephrol Dial Transplant 19 1902 1906 2004
8. Behets GJ Dams G Vercauteren SR Damment SJ Bouillon R De Broe ME D'Haese PC Does the phosphate binder lanthanum carbonate affect bone in rats with chronic renal failure? J Am Soc Nephrol 15 2219 2228 2004
9. Damment SJ Shen V Assessment of effects of lanthanum carbonate with and without phosphate supplementation on bone mineralization in uremic rats. Clin Nephrol 63 127 137 2005
10. Behets GJ Verberckmoes SC Oste L Bervoets AR Salome M Cox AG Denton J De Broe ME D'Haese PC Localization of lanthanum in bone of chronic renal failure rats after oral dosing with lanthanum carbonate. Kidney Int 67 1830 1836 2005
11. Lacour B Lucas A Auchere D Ruellan N de Serre Patey NM Drueke TB Chronic renal failure is associated with increased tissue deposition of lanthanum after 28-day oral administration. Kidney Int 67 1062 1069 2005
12. Freemont T Malluche HH Utilization of bone histomorphometry in renal osteodystrophy: demonstration of a new approach using data from a prospective study of lanthanum carbonate. Clin Nephrol 63 138 145 2005
13. D'Haese PC Spasovski GB Sikole A Hutchison A Freemont TJ Sulkova S Swanepoel C Pejanovic S Djukanovic L Balducci A Coen G Sulowicz W Ferreira A Torres A Curic S Popovic M Dimkovic N De Broe ME A multicenter study on the effects of lanthanum carbonate (Fosrenol) and calcium carbonate on renal bone disease in dialysis patients. Kidney Int Suppl 63 S73 S78 2003
14. Ballanti P Coen G Mazzaferro S Taggi F Giustini M Calabria S Ferrannini M Bonucci E Histomorphometric assessment of bone turnover in uraemic patients: comparison between activation frequency and bone formation rate. Histopathology 38 571 583 2001
15. National Kidney Foundation K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42 4 suppl 3 S1 S201 2003
16. Martin KJ Olgaard K Coburn JW Coen GM Fukagawa M Langman C Malluche HH McCarthy JT Massry SG Mehls O Salusky IB Silver JM Smogorzewski MT Slatopolsky EM McCann L Diagnosisassessmentand treatment of bone turnover abnormalities in renal osteodystrophy. Am J Kidney Dis 43 558 565 2004
17. Young EW Albert JM Satayathum S Goodkin DA Pisoni RL Akiba T Akizawa T Kurokawa K Bommer J Piera L Port FK Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study. Kidney Int 67 1179 1187 2005
18. Block GA Hulbert-Shearon TE Levin NW Port FK Association of serum phosphorus and calcium × phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 31 607 617 1998
19. Block G Port FK Calcium phosphate metabolism and cardiovascular disease in patients with chronic kidney disease. Semin Dial 16 140 147 2003
20. Malluche HH Faugere M-C Wang G Damment SJP Webster I No evidence of osteomalacia in dialysis patients treated with lanthanum carbonate up to 5 years [abstract]. J Am Soc Nephrol 15 270A 2004
21. Damment SJP Gill M Con fer S Jones C Pennick M The bone kinetics of lanthanum in dialysis patients treated with lanthanum carbonate for 4.5 years [abstract]. J Am Soc Nephrol 13 271A 2004
22. Lindsay RM Alhejaili F Nesrallah G Leitch R Clement L Heidenheim AP Kortas C Calcium and phosphate balance with quotidian hemodialysis. Am J Kidney Dis 42 suppl 1 24 29 2003